Table 1 Baseline patient demographic and disease characteristics of PRO cohort
PRO Cohort, n = 309 | |
|---|---|
Age in years, mean (SD) | 14.99 (2.74) |
Categorical age in years, n (%) | |
5 to 10.9 | 29 (9.39) |
11 to 17.9 | 257 (83.17) |
18–21.9 | 23 (7.44) |
Sex, n (%) | |
Female | 156 (50.49) |
Male | 153 (49.51) |
Race/Ethnicity, n (%) | |
Hispanic | 54 (17.48) |
Non-Hispanic Black | 31 (10.03) |
Non-Hispanic White | 189 (61.17) |
Other and Unknown | 35 (11.33) |
Histology, n (%) | |
Nodular sclerosis | 240 (77.67) |
Mixed cellularity | 13 (4.21) |
NOS | 52 (16.83) |
Lymphocyte-rich | 4 (1.30) |
Stage | |
Stage IIB with Bulk | 67 (21.68) |
Stage III | 63 (20.39) |
Stage IVA | 76 (24.60) |
Stage IVB | 103 (33.33) |